Immunomodulatory compounds that target and inhibit the pY'binding site of tyrosene kinase p56 LCK SH2 domain
申请人:Mackerell Alexander
公开号:US20070099970A1
公开(公告)日:2007-05-03
Small molecular-weight non-peptidic compounds block Lck SH2 domain-dependent interactions. The inhibitors omit phosphotyrosine (pY) or related moieties.
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
申请人:Mackerell Alexander
公开号:US20070196395A1
公开(公告)日:2007-08-23
Small molecular-weight non-peptidic compounds block Lck SH2 domain-dependent interactions. The inhibitors omit phosphotyrosine (pY) or related moieties.
[EN] SALTS OF PAROXETINE<br/>[FR] SELS DE PAROXETINE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2000001692A1
公开(公告)日:2000-01-13
Piperidine compounds, processes for preparing them, pharmaceutical compositions comprising them and their use in therapy are disclosed.
[EN] IMMUNOMODULATORY COMPOUNDS THAT TARGET AND INHIBIT THE PY+3 BINDING SITE OF TYROSENE KINASE P56 LCK SH2 DOMAIN<br/>[FR] COMPOSES IMMUNOMODULATEURS QUI CIBLENT ET INHIBENT LE SITE DE LIAISON PY+3 DU DOMAINE SH2 DE LA TYROSINE KINASE P56 LCK
申请人:UNIV MARYLAND
公开号:WO2008024759A2
公开(公告)日:2008-02-28
[EN] Small molecular-weight non-peptidic compounds block Lck SH2 domain-dependent interactions. The inhibitors omit phosphotyrosine (pY) or related moieties. [FR] L'invention concerne des composés non peptidiques de faible poids moléculaire qui bloquent les interactions dépendantes du domaine SH2 de la Lck. Lesdits inhibiteurs omettent la phosphotyrosine (pY) ou des fractions associées.